These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiac tamponade complicating myocardial infarction in the era of thrombolytics and platelet IIb/IIIa: case report and literature review. Mixon TA; Tak T; Lawrence ME Am J Geriatr Cardiol; 2001; 10(3):133-8. PubMed ID: 11360837 [TBL] [Abstract][Full Text] [Related]
5. Transvenous pacing causing tamponade in patients receiving glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention. Jeilan M; Richardson G; Gershlick A J Invasive Cardiol; 2007 Feb; 19(2):E40-2. PubMed ID: 17268050 [No Abstract] [Full Text] [Related]
6. Takotsubo cardiomyopathy complicated by cardiac tamponade due to non-hemorrhagic pericardial effusion: a case report. Nagamori Y; Hamaoka T; Murai H; Takashima S; Kato T; Usui S; Sakata K; Furusho H; Kawashiri M; Takamura M BMC Cardiovasc Disord; 2020 Feb; 20(1):67. PubMed ID: 32028901 [TBL] [Abstract][Full Text] [Related]
7. Duration of action of GpIIb-IIIa antagonists. Johnson K Crit Care Nurse; 2000 Oct; 20(5):16. PubMed ID: 11878484 [No Abstract] [Full Text] [Related]
9. Assessing platelet function during treatment with glycoprotein IIb/IIIa antagonists. Steinhubl SR Coron Artery Dis; 2003 Aug; 14(5):381-6. PubMed ID: 12878903 [No Abstract] [Full Text] [Related]
10. [The use of BP IIb/IIIa inhibitors]. Polimeno S; De Rosa V Ital Heart J Suppl; 2000 Jul; 1(7):958-61. PubMed ID: 10935749 [No Abstract] [Full Text] [Related]
11. [Pathophysiology, clinical and experimental possibilities of pericardial tamponade]. Bari G; Érces D; Varga G; Szűcs S; Bogáts G Orv Hetil; 2018 Feb; 159(5):163-167. PubMed ID: 29376423 [TBL] [Abstract][Full Text] [Related]
13. [Antagonists of the GPIIb/IIIa platelet receptor]. Gomes ME; Fabris C; B filho JL; Dreher R; Rosito GA Rev Assoc Med Bras (1992); 2000; 46(3):255-64. PubMed ID: 11070517 [No Abstract] [Full Text] [Related]